Katie Coleman named senior advisor for translational innovation at OSUCC–James

The Mark Foundation names 2026 Emerging Leader Award recipients

The Mark Foundation for Cancer Research announced the recipients of the 2026 Emerging Leader Awards, recognizing five early-career scientists poised to make significant impacts in oncology.

January 16, 2026

Vol.52 No.02

In Brief

Alex Bates named director for executive communications at the OSUCCC–James

Alex Bates was appointed director of executive communications for the Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

January 16, 2026

Vol.52 No.02

In Brief

Will Parsons named director of Texas Children’s Cancer and Hematology Center

Will Parsons was appointed as chief of the Division of Hematology-Oncology in the Department of Pediatrics at Baylor College of Medicine and director of Texas Children’s Cancer and Hematology Center, effective immediately.

January 09, 2026

Vol.52 No.1

In Brief

Robert Negrin begins term as 2026 ASH president

Robert S. Negrin, professor of medicine at Stanford University, will serve as president of the American Society of Hematology for a year-long term through December 2026.

January 09, 2026

Vol.52 No.1

In Brief

Josh Cooper named EVP, government relations at ACR

Joshua J. Cooper has been named executive vice president of government relations, economics, and health policy at the American College of Radiology.

January 09, 2026

Vol.52 No.1

Cancer Policy

Angelo de Claro named acting director of FDA Oncology Center of Excellence

Angelo de Claro was named acting director of the FDA Oncology Center of Excellence, following Richard Pazdur’s departure from that position—and the agency (The Cancer Letter, Dec. 5, 2025).

December 19, 2025

Vol.51 No.46

By Jacquelyn Cobb